Informative message
No topics foundNITAG recommendations
Thu, 09/14/2023 - 05:24
Approved vaccination with third dose of Pfizer mRNA SARS-coV2 vaccine to adolescentsvaged 12 to 17 years; Immunocompromised persons who have received CoronaVac + CoronaVac Pfizer_BioNtech + Pfizer-BioNtech: Fifth dose of Pfizer mRNA platform vaccine to 6 months after last dose; Immunocompromised
Thu, 09/14/2023 - 05:23
The country must continue making efforts to complete the basic schedule plus a booster dose; Based on current national and international scientific and epidemiological evidence, a second booster dose is established 4 months after the application of the initial booster starting on Monday, April 4